Table 1.

Description of the vitronectin and nuclei morphometric measurements of control tissues and NB primary tumors

Parameter			Median	Mean	SD	Range	Q3
Normal control tissues other than liver (n = 12)
IPP	Nuclei	Density	308.10	305	99.75	94.10–477.70	355
		%SA	7.30	7.90	3.35	4–14	8.80
	Inter. VN	%SA	1.57	3.92	5.70	0.42–17	3.67
	Terr. VN	%SA	0.04	0.07	0.07	0–0.20	0.15
Densito	VN ratio of pixels	Weak	0.04	1	1.50	0–4	1.75
		Moderate	2.25	10.95	13	0.06–35	22.90
		Strong	1	2	2.60	0–9	2.95
	H-score		20.45	46.40	52.51	0.16–163	82.50
Liver samples (n = 5)
IPP	Nuclei	Density	616	1846.70	2384.30	472–6051.70	3767.80
		%SA	4	3.80	2.05	2–7	5.50
	Inter. VN	%SA	20	19	11.40	3–31	29.50
	Terr. VN	%SA	3	2.50	1.30	0.65–4	3.50
Densito	VN ratio of pixels	Weak	2.50	2.85	2.30	0.30–6	5.15
		Moderate	67	64.55	8.30	50–71	69.50
		Strong	12.75	13.50	2.70	10–17	16
	H-score		175.80	172.60	11.60	152.25–181.35	179.55
Primary tumors (n = 91)
IPP	Nuclei	Density	560	1074.25	1455.80	95–6793	739
		%SA	11.75	11.70	6.30	0.35–29.70	15.50
	Inter. VN	%SA	9.35	12.25	10.95	0.02–40.97	18.20
	Terr. VN	%SA	0.71	2.95	4.45	0.01–20.70	4.50
Densito	VN ratio of pixels	Weak	0.80	1.60	2.40	0.01–14.65	2.10
		Moderate	35	36.10	24.70	0.05–88.10	56.75
		Strong	3.55	12.85	17.85	0.01–61.85	20.40
	H-score		110.91	112.85	78.55	1.07–257.60	183.80

Descriptors of vitronectin (VN) immunoreactivity and nuclei according to their morphometric measurements are shown. IPP: Image Pro-Plus; Densito: DensitoQuant; Inter.VN: Interterritorial VN; Terr.VN: Territorial VN. Density: number of objects/mm²; %SA: percentage of stained area. SD: Standard deviation; Q₃: third quartile